AMRN Q1 2023 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M-9.1% YoY

Gross Profit

$48M55.7% margin

Operating Income

-$17M-20.2% margin

Net Income

-$16M-19.1% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$860M

Total Liabilities

$275M

Stockholders' Equity

$585M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$95M	-9.1%
Gross Profit	$48M	$72M	-33.8%
Operating Income	-$17M	-$28M	+38.7%
Net Income	-$16M	-$32M	+47.9%

Revenue Segments

Product

$85M98%

Licensing And Royalty

$1M2%